Sign in
4

Changes in Ownership

Larimar Therapeutics, Inc. Filed Acc 0000899243-23-003735

Chief Financial Officer acquired 76,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Celano Michael Chief Financial Officer 2023-01-31 Grant or award +76,000 107,746 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Celano Michael Chief Financial Officer 2023-01-31 Grant or award · Stock Option (Right to Buy) +120,000 120,000 D: show line 2 in the form
Loading xslF345X03/doc4.xml…